ArticleJAMA internal medicine2015

Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness.

Purav Mody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.